Cm Management, LLC Heron Therapeutics, Inc. Transaction History

Cm Management, LLC

$115 Million
Q1 2024

A detailed history of Cm Management, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 300,000 shares of HRTX stock, worth $831,000. This represents 0.72% of its overall portfolio holdings.

Number of Shares

300,000

Previous 325,000 7.69%

Holding current value

$831,000

Previous $552,000 50.54%

% of portfolio

0.72%

Previous 0.46%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.71 - $3.06 $42,750 - $76,500	-25,000 Reduced 7.69%	300,000 $831,000
Q4 2023 Feb 12, 2024	SELL	$0.54 - $1.82 $67,500 - $227,500	-125,000 Reduced 27.78%	325,000 $552,000
Q3 2023 Nov 07, 2023	SELL	$0.97 - $1.8 $48,500 - $90,000	-50,000 Reduced 10.0%	450,000 $463,000
Q2 2023 Aug 04, 2023	BUY	$1.11 - $2.88 $166,500 - $432,000	150,000 Added 42.86%	500,000 $580,000
Q1 2023 May 08, 2023	BUY	$1.51 - $3.25 $151,000 - $325,000	100,000 Added 40.0%	350,000 $529,000

Q4 2022 Feb 09, 2023	SELL	$2.25 - $4.67 $56,250 - $116,750	-25,000 Reduced 9.09%	250,000 $625,000
Q3 2022 Nov 04, 2022	BUY	$2.66 - $5.37 $199,500 - $402,750	75,000 Added 37.5%	275,000 $1.16 Million
Q1 2022 May 09, 2022	BUY	$4.63 - $9.94 $694,500 - $1.49 Million	150,000 Added 300.0%	200,000 $1.14 Million
Q4 2021 Feb 02, 2022	SELL	$8.35 - $12.6 $83,500 - $126,000	-10,000 Reduced 16.67%	50,000 $457,000
Q3 2021 Nov 08, 2021	BUY	$10.13 - $15.0 $101,300 - $150,000	10,000 Added 20.0%	60,000 $641,000
Q1 2021 May 12, 2021	BUY	$14.49 - $20.72 $507,150 - $725,200	35,000 Added 233.33%	50,000 $811,000
Q4 2020 Feb 04, 2021	BUY	$14.61 - $22.14 $219,150 - $332,100	15,000 New	15,000 $317,000

Others Institutions Holding HRTX

# of Institutions

168

Shares Held

119M

Call Options Held

151K

Put Options Held

103K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $329M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.

Account

Cm Management, LLC Heron Therapeutics, Inc. Transaction History